Respiratory epithelium: Place of entry and / or defense against SARS-CoV-2 virus

Snežana Leštarević Orcid logo ,
Snežana Leštarević
Slađana Savić Orcid logo ,
Slađana Savić
Leonida Vitković ,
Leonida Vitković
Predrag Mandić ,
Predrag Mandić
Milica Mijović ,
Milica Mijović
Mirjana Dejanović ,
Mirjana Dejanović
Dragan Marjanović ,
Dragan Marjanović
Ivan Rančić ,
Ivan Rančić
Milan Filipović
Milan Filipović

Published: 01.12.2020.

Volume 50, Issue 1 (2021)

pp. 35-43;

https://doi.org/10.5937/pramed2102035l

Abstract

Coronavirus Disease (COVID-19) is caused by the RNA virus SARS-CoV-2. The primary receptor for the virus is most likely Angiotensin-converting enzyme 2 (ACE2), and the virus enters the body by infecting epithelial cells of the respiratory tract. Through the activation of Toll Like Receptors (TLRs), epithelial cells begin to synthesize various biologically active molecules. The pathophysiology of the COVID 19 is primarily attributed to the hyperactivation of host's immune system due to direct damage to the cells, with consequent release of proinflammatory substances, but also due to the activation of the innate immune response through the activation of alveolar macrophages and dendrite cells (DC). A strong proinflammatory reaction causes damage to alveolar epithelial cells and vascular endothelium. Respiratory epithelial cells, alveolar macrophages and DC are likely to be the most important cells involved in the innate immune response to the virus, since prolonged and excessive SARS-CoV-2-induced activation of these cells leads to the secretion of cytokines and chemokines that massively attract leukocytes and monocytes to the lungs and cause lung damage.

Keywords

References

1.
Ueno H, Matsuda T, Hashimoto S, Amaya F, Kitamura Y, Tanaka M, et al. Contributions of High Mobility Group Box Protein in Experimental and Clinical Acute Lung Injury. American Journal of Respiratory and Critical Care Medicine. 2004;170(12):1310–6.
2.
Stark K. Platelet‐neutrophil crosstalk and netosis. HemaSphere. 2019;3(S2):89–91.
3.
Lin S, Wu H, Wang C, Xiao Z, Xu F. Regulatory T Cells and Acute Lung Injury: Cytokines, Uncontrolled Inflammation, and Therapeutic Implications. Frontiers in Immunology. 9.
4.
Wong JJM, Leong JY, Lee JH, Albani S, Yeo JG. Insights into the immuno-pathogenesis of acute respiratory distress syndrome. Annals of Translational Medicine. 2019;7(19):504–504.
5.
Mitroulis I, Alexaki VI, Kourtzelis I, Ziogas A, Hajishengallis G, Chavakis T. Leukocyte integrins: Role in leukocyte recruitment and as therapeutic targets in inflammatory disease. Pharmacology & Therapeutics. 2015;147:123–35.

Citation

Copyright

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Indexed by